Glucotrack, Inc. Files 8-K Report

Ticker: GCTK · Form: 8-K · Filed: May 20, 2025 · CIK: 1506983

Glucotrack, INC. 8-K Filing Summary
FieldDetail
CompanyGlucotrack, INC. (GCTK)
Form Type8-K
Filed DateMay 20, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-disclosure, 8-k

TL;DR

Glucotrack filed an 8-K today, mostly financial docs. Nothing major announced.

AI Summary

On May 20, 2025, Glucotrack, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update or disclosure related to the company's financial status. No specific material events or transactions were detailed in the provided excerpt.

Why It Matters

This filing serves as a public record of Glucotrack, Inc.'s financial disclosures, providing transparency to investors and the market.

Risk Assessment

Risk Level: low — The filing appears to be a standard disclosure of financial statements and exhibits, with no immediate indication of significant risks or material events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Glucotrack, Inc.?

The primary purpose of this 8-K filing is to report financial statements and exhibits, as indicated by the 'ITEM INFORMATION' section.

What is the exact date of the earliest event reported in this filing?

The date of the earliest event reported is May 20, 2025.

In which state was Glucotrack, Inc. incorporated?

Glucotrack, Inc. was incorporated in Delaware.

What is the Commission File Number for Glucotrack, Inc.?

The Commission File Number for Glucotrack, Inc. is 001-41141.

What is the principal executive office address for Glucotrack, Inc.?

The principal executive office address is 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 20, 2025 regarding Glucotrack, Inc. (GCTK).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing